Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (7)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Pileri, S. A.
Right arrow Articles by Bendandi, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pileri, S. A.
Right arrow Articles by Bendandi, M.
Related Collections
Right arrow 2004 - Review Articles
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Annals of Oncology 15:12-18, 2004
© 2004 European Society for Medical Oncology

Indolent lymphoma: the pathologist’s viewpoint

Received 30 April 2003; accepted 7 August 2003

Indolent lymphomas have recently been the object of numerous studies, which have focused on new aspects relevant both for the better comprehension of their histogenesis and the identification of new therapeutic strategies. As marginal-zone lymphoma (MZL) represents the category of indolent lymphomas that has obtained more benefit from such an approach, the authors focused on the most recent achievements and not yet solved controversies in this area. In spite of their postulated common derivation, the three categories of MZL of the WHO Classification appear dissimilar. In fact, they show significant molecular differences among them as well as a certain heterogeneity within each group. By no means, there is a cogent need of more refined tools to revise these neoplasms and to produce a more rational grouping. The recent identification of the IRTA gene family corresponding to IG-like receptors differentially expressed in B-cells might contribute to their better understanding.

S. A. Pileri1,*, P. L. Zinzani2, P. Went3, A. Pileri Jr1 and M. Bendandi4,§

1 Pathologic Anatomy and Unit of Haematopathology, Institute of Haematology and Clinical Oncology ‘L. & A. Seràgnoli’, Bologna University; 2 Lymphoma Unit, Institute of Haematology and Clinical Oncology ‘L. & A. Seràgnoli’, Bologna University, Bologna, Italy; 3 Institute of Pathology, University Hospital Basel, Basel, Switzerland; 4 Department of Haematology and Cell Therapy Area, University Clinic, University of Navarra, Pamplona, Spain

Key words: extranodal marginal zone lymphoma, indolent lymphoma, lymphoma classification, nodal marginal zone lymphoma, primary splenic marginal zone lymphoma


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 JCOHome page
S. de Vos, A. Goy, S. R. Dakhil, M. N. Saleh, P. McLaughlin, R. Belt, C. R. Flowers, M. Knapp, L. Hart, D. Patel-Donnelly, et al.
Multicenter Randomized Phase II Study of Weekly or Twice-Weekly Bortezomib Plus Rituximab in Patients With Relapsed or Refractory Follicular or Marginal-Zone B-Cell Lymphoma
J. Clin. Oncol., October 20, 2009; 27(30): 5023 - 5030.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
C. A. Huff, W. Matsui, B. D. Smith, and R. J. Jones
The paradox of response and survival in cancer therapeutics
Blood, January 15, 2006; 107(2): 431 - 434.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.